Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Tom DuBois who wrote (3318)	12/15/1997 10:44:00 AM
From: Peter Singleton	Respond to of 6136

I posted a similar note on MF. Impugning someone's person for comments you disagree with is counter-productive. First, it stifles debate. People are less likely to raise important issues and questions about a company, its products and technology or valuation, if they expect to be attacked personally for doing so. So, those of us who want to understand the company and its prospects lose. Second, in doing so you fail to address whatever issues the person raises, further lowering the quality of discussion. Third, it drives away serious investors and biotechnologists who have a significant contribution to make to this debate. This thread becomes a waste of time for all of us. Fourth, it's disrespectful of the person you are attacking. Guys, let's stay on point. This has been a somewhat useful forum for the exchange of information and opinion ... let's try and keep it that way. TIA, Peter